Method for treating ocular demodex
Abstract
The present invention relates to a method for treating a disorder chosen from ocular Demodex, Demodex -induced blepharitis, rosacea, acne, and meibomian gland dysfunction in a patient in need thereof, comprising administering to the patient a composition comprising a therapeutically effective amount of a substance chosen from at least one of an isoprenoidal essential oil such as Tea Tree Oil; Terpinen-4-ol; (+)-Carvone; alpha-Terpineol; Cardinene; d-Carvone; l-Carvone; gamma-Terpinene; alpha-Terpinene; 1,8-Cineole; alpha-Terpineol; para-Cimene; alpha-Pinene; Limonene; (R)-(+)-Limonene; alpha-Thugene; Eucalyptol; (+)-Ledene; Cuminic Aldehyde; and Myrcene; the administration comprising contacting or scrubbing an affected area of skin or hair, or eyelid margin and lashes of the patient with the composition; also disclosed are a method for treating mange and mite infestations on a mammalian animal; and kits for in-office and at home treatments of the disorders.
Claims
exact text as granted — not AI-modified1 - 28 . (canceled)
29 . An ophthalmic composition comprising a therapeutically effective amount of tea tree oil.
30 . The composition of claim 29 , wherein the therapeutically effective amount is about 20% to about 100% tea tree oil.
31 . The composition of claim 30 , wherein the therapeutically effective amount is about 50% tea tree oil.
32 . The composition of claim 29 , further comprising a pharmaceutically acceptable carrier.
33 . The composition of claim 29 , wherein the composition is effective for the treatment of an ocular Demodex infestation, Demodex -induced blepharitis, rosacea, acne, or meibomian gland dysfunction.
34 . The composition of claim 33 , wherein the composition is effective for the treatment of an ocular Demodex infestation.
35 . An ophthalmic composition for treating a Demodex infestation, the composition comprising a therapeutically effective amount of terpinen-4-ol, (+)-carvone, or any combination thereof, and a pharmaceutically acceptable carrier.
36 . The composition of claim 35 , comprising about 50% (+)-carvone.
37 . The composition of claim 35 , wherein the composition is effective for the treatment of an ocular Demodex infestation, Demodex -induced blepharitis, rosacea, acne, or meibomian gland dysfunction.
38 . The composition of claim 37 , wherein the composition is effective for the treatment of a Demodex infestation.
39 . A method for treating ocular Demodex infestation or Demodex -induced blepharitis in a subject in need thereof comprising: administering an ophthalmic composition comprising a therapeutically effective amount of tea tree oil to the eyelid area, and contacting the composition with the eyelid margin and eyelash root areas until sufficient to achieve a desired effect.
40 . The method of claim 39 , wherein the ophthalmic composition comprises about 20% to about 100% tea tree oil.
41 . The method of claim 40 , wherein the ophthalmic composition comprises about 50% tea tree oil.
42 . The method of claim 39 , further comprising a pharmaceutically acceptable carrier.
43 . The method of claim 39 , wherein the subject shows improvement in ocular itching, Demodex count, foreign body sensation, misdirected lashes, dry eye, redness, light-sensitivity, or any combination thereof.
44 . The method of claim 39 , wherein the subject is refractory to an anti-inflammatory, conventionally anti-microbial antibiotic, or an anti-allergy therapy for ocular Demodex infestation or Demodex -induced blepharitis.
45 . The method of claim 39 , further comprising scrubbing the eyelid margin and eyelash root areas with a shampoo, gel, solution or suspension comprising tea tree oil before or after applying the composition.
46 . The method of claim 45 , wherein the shampoo, gel, solution or suspension is a tea tree oil shampoo.
47 . A method for treating ocular Demodex infestation or Demodex -induced blepharitis in a subject in need thereof comprising: administering an ophthalmic composition comprising a therapeutically effective amount of terpinen-4-ol or (+)-carvone, or any combination thereof, and a pharmaceutically acceptable carrier, to the eyelid area; and contacting the ophthalmic composition onto the eyelid margin and eyelash root areas until sufficient to achieve a desired effect.
48 . The method of claim 47 , wherein the ophthalmic composition comprises about 50% (+)-carvone.
49 . The method of claim 47 , further comprising scrubbing the eyelid margin and eyelash root areas with a shampoo, gel, solution or suspension comprising tea tree oil before or after applying the composition.
50 . A dermatologic composition comprising a therapeutically effective amount of tea tree oil and a pharmaceutically acceptable carrier.
51 . The composition of claim 50 , wherein the therapeutically effective amount is about 50% tea tree oil.
52 . The composition of claim 50 , wherein the composition is effective for the treatment of a dermatologic Demodex infestation, Demodex -induced blepharitis, rosacea, acne, or meibomian gland dysfunction.
53 . The composition of claim 52 , wherein the composition is effective for the treatment of a dermatologic Demodex infestation.Join the waitlist — get patent alerts
Track US2009214676A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.